{
    "code": "52026407",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026407",
    "time": "2023-09-21 19:55:05",
    "許可證字號": "衛部藥輸字第026407號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/02\/03",
    "發證\/登錄日期": "104\/02\/03",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202640706",
    "中文品名": "汰威凱膜衣錠50毫克",
    "英文品名": "Tivicay Film-Coated Tablets 50mg",
    "適應症": "與其他抗反轉錄病毒藥物合併用於治療成人及12歲以上青少年的人類免疫不全病毒(HIV)感染症。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠以下塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/02\/03",
    "主成分略述": "Dolutegravir Sodium",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": [
        {
            "製造廠名稱": "GLAXO OPERATIONS UK LIMITED",
            "製造廠廠址": "PRIORY STREET,WARE,HERTFORDSHIRE SG12 0DJ,UNITED KINGDOM.",
            "製造廠公司地址": "-",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "GLAXO WELLCOME, S.A.",
            "製造廠廠址": "AVENIDA EXTREMADURA 3, ARANDA de DUERO, BURGOS 09400, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "包裝及分裝"
        },
        {
            "製造廠名稱": "VIIV HEALTHCARE UK LIMITED",
            "製造廠廠址": "980 GREAT WEST ROAD BRENTFORD MIDDLESEX, TW8 9GS, UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818004700",
            "成分名稱": "Dolutegravir Sodium",
            "含量描述": "(Equivalent to 50mg Dolutegravir)",
            "含量": "52.6000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "1cm*1cm 錠劑",
        "特殊劑型": "",
        "顏色": "黃色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "圓凸形",
        "標記一": "SV 572",
        "標記二": "50"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "520264070004-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026407&Seq=004&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Tivicay leaflet-110-10-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026407&Seq=007&Type=9"
        },
        {
            "title": "02026407_Tivicay Film Coated tablets 50mg_C-107-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026407&Seq=005&Type=8"
        }
    ]
}